Hey there!

I'm a Harvard Economics sophomore interested in the intersection of finance, healthcare, and biotechnology, with experience spanning private equity, corporate transactions, and healthcare entrepreneurship.

At Cedarlake Capital, I engineered 5-year LBO models for $250M buyouts and helped unearth $22M in hidden EBITDA. At Clifford Chance, I jumped headfirst into M&A advisory, dissecting legal risks on a $1.1B cross-border transaction and navigating complex takeover rules.

Add in stress-testing returns at Longcrest Partners and interviewing top VC investors on a media platform scaled to 100k+ listens—let's just say I'm happiest right in the thick of market action.

Trilingual in English, Mandarin, and Cantonese—and always fluent in deal flow. Open to connecting over transaction mechanics, market plays, or Harvard's investment scene. Give me a shout...